Patents Assigned to PLEOPHARMA, INC.
  • Methods and compositions for treating cannabis use disorder and mitigating cannabinoid withdrawal
    Patent number: 11931334
    Abstract: The present invention provides methods of treating cannabis withdrawal syndrome and other cannabis related conditions, including cannabis use disorder, in a subject, comprising administering to the subject in need thereof an effective amount of a cannabinoid or an effective amount of a cannabinoid and an effective amount of a second active agent, such as gabapentin or a gabapentin analog.
    Type: Grant
    Filed: December 9, 2021
    Date of Patent: March 19, 2024
    Assignee: PLEOPHARMA, INC.
    Inventor: Ginger D. Constantine